If you want a treatment plan tailored to your physiology rather than a generic protocol, work with us
Understanding these key differences can help you make an informed decision about effective weight management approaches that align with your health goals
Single-cell transcriptomics reveal immune mechanisms of the onset and progression of IgA nephropathy
When appetite is low, having quick, reliable protein options is a game-changer
BPC 157 antagonized portal/caval hypertension (caval portal hypertension), and aortal hypotension, refractory ascites and thrombosis (portal vein tributaries, inferior vena cava, hepatic and coronary arteries), pathology of the lungs (severe capillary congestion) and liver (dilated central veins and terminal portal venules), intestine hemorrhagic lesions (substantial capillary congestion, submucosal edema and architecture loss), increased liver and spleen weight serum and enzymes values, NO- and MDA-levels in the liver
Current FDA-approved treatment options for BED are limited